SCHEMBL7364657

SCHEMBL7364657

[CH2]c1ccccc1C(O)CC

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
TSHR P16473 1/20 0.42
PDE2A O00408 1/20 0.37
TRPA1 O75762 2/20 0.34
ADRB2 P07550 2/20 0.34
ADRB1 P08588 2/20 0.34
AOC3 Q16853 2/20 0.34
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
HIF1A Q16665 1/20 0.33
CASP1 P29466 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30172716 0.84 LMNA (0.61) LMNATSHRPDE2ATRPA1ADRB2
SCHEMBL5107130 0.84 LMNA (0.61) LMNATSHRPDE2ATRPA1ADRB2
SCHEMBL5107133 0.84 LMNA (0.61) LMNATSHRPDE2ATRPA1ADRB2
SCHEMBL5107136 0.84 LMNA (0.61) LMNATSHRPDE2ATRPA1ADRB2
SCHEMBL9219679 0.82 LMNA (0.33) LMNATSHRTRPA1ADRB2ADRB1
SCHEMBL814926 0.77 TSHR (0.40) LMNATSHRTRPA1GABRA1GABRB2
SCHEMBL5907398 0.77 LMNA (0.54) LMNATSHRPDE2ATRPA1ADRB2
SCHEMBL593087 0.76 LMNA (0.52) LMNATSHRPDE2ATRPA1ADRB2
SCHEMBL2990957 0.76 TSHR (0.65) LMNATSHRPDE2ATRPA1ADRB1
SCHEMBL28639572 0.76 LMNA (0.52) LMNATSHRPDE2ATRPA1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815108-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-07 EP claimed
WO-1996029329-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-26 WO claimed
US-9074021-B2 Cellulose derivative, thermo-molding material, molded body and method for preparation thereof, and case for electric and electronic devices FUJIFILM CORPORATION (JP) 2015-07-07 US disclosed
EP-2465899-B1 CELLULOSE DERIVATIVE, THERMOFORMED MATERIAL, MOLDED BODY, PRODUCTION METHOD THEREFOR, AND CASING FOR ELECTRICAL AND ELECTRONIC EQUIPMENT FUJIFILM CORP (JP) 2014-11-05 EP disclosed
US-20120165517-A1 CELLULOSE DERIVATIVE, THERMO-MOLDING MATERIAL, MOLDED BODY AND METHOD FOR PREPARATION THEREOF, AND CASE FOR ELECTRIC AND ELECTRONIC DEVICES FUJIFILM CORPORATION (JP) 2012-06-28 US disclosed
EP-2465899-A1 CELLULOSE DERIVATIVE, THERMOFORMED MATERIAL, MOLDED BODY, PRODUCTION METHOD THEREFOR, AND CASING FOR ELECTRICAL AND ELECTRONIC EQUIPMENT FUJIFILM Corporation (JP) 2012-06-20 EP disclosed
WO-1996029329-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-26 WO disclosed
US-4831041-A ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 US disclosed
EP-0268989-A1 Imidazopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-01 EP disclosed